Clinical and serological characteristics of patients with systemic sclerosis
| Characteristic | Value |
|---|---|
| Controls: | |
| Gender | (N=698)* |
| Female | 334 (50.8) |
| Male | 323 (49.2) |
| Systemic sclerosis: | |
| Gender | (N=1059) |
| Female | 935 (88.3) |
| Male | 124 (11.7) |
| Skin involvement | (N=1004) |
| Limited systemic sclerosis | 611 (60.9) |
| Diffuse systemic sclerosis | 393 (39.1) |
| SSc-associated autoantibodies | (N=1059) |
| Anti-centromere | 300 (28.3) |
| Anti-topoisomerase I | 174 (16.4) |
| Anti-RNA polymerase III | 193 (18.2) |
| Neither anti-centromere, anti-topoisomerase I, or anti-RNA polymerase III | 392 (37.1) |
Values are number (%).
↵* Missing gender information on 41 controls.